Lineage Cell Therapeutics Inc Sustainability Reports
A clinical-stage biotechnology company that develops novel cell-based therapies for unmet medical needs.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
LEI: 5299002BI4W22SDF8R25
FIGI: BBG001SCW8V3
8 reports from 2019 to 2025
